These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 10827147)

  • 1. Autoimmune cholangitis within the spectrum of autoimmune liver disease.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Hepatology; 2000 Jun; 31(6):1231-8. PubMed ID: 10827147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
    Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
    Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?].
    Saló J; Caballería L; Bruguera M; Parés A; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):5-10. PubMed ID: 9072202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap syndromes.
    Beuers U; Rust C
    Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune cholangitis or seronegative biliary cirrhosis: report of one case].
    Ndongo S; Mbengue M; Dia D; Seck SM; Ka MM; Moreira Diop T
    Dakar Med; 2008; 53(2):127-30. PubMed ID: 19634547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
    Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
    Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.
    Arulprakash S; Sasi AD; Bala MR; Pugazhendhi T; Kumar SJ
    J Assoc Physicians India; 2010 Jul; 58():455-6. PubMed ID: 21121216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.
    Boberg KM; Fausa O; Haaland T; Holter E; Mellbye OJ; Spurkland A; Schrumpf E
    Hepatology; 1996 Jun; 23(6):1369-76. PubMed ID: 8675153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and nature of the variant syndromes of autoimmune liver disease.
    Czaja AJ
    Hepatology; 1998 Aug; 28(2):360-5. PubMed ID: 9695997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A spectrum of histopathologic findings in autoimmune liver disease.
    Terracciano LM; Patzina RA; Lehmann FS; Tornillo L; Cathomas G; Mhawech P; Vecchione R; Bianchi L
    Am J Clin Pathol; 2000 Nov; 114(5):705-11. PubMed ID: 11068543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
    Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
    Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
    Cabibi D; Tarantino G; Barbaria F; Campione M; Craxì A; Di Marco V
    Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
    van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR
    Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis].
    Schedel J; Mayer S; Woenckhaus M; Kiss E; Schölmerich J; Rogler G
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2409-12. PubMed ID: 15529241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
    Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
    J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.